An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer

TerminatedOBSERVATIONAL
Enrollment

78

Participants

Timeline

Start Date

July 7, 2023

Primary Completion Date

May 29, 2024

Study Completion Date

May 29, 2024

Conditions
Breast Cancer
Interventions
OTHER

None (Observational Study)

Not Applicable since observational study

Trial Locations (125)

1010

Research Site, Vienna

1870

Research Site, Monthey

3010

Research Site, Bern

4031

Research Site, Basel

6020

Research Site, Innsbruck

8036

Research Site, Graz

10003

Research Site, Cáceres

10126

Research Site, Torino

11042

Research Site, Lake Success

11407

Research Site, Jerez de la Frontera

11432

Research Site, Jamaica

14004

Research Site, Córdoba

15006

Research Site, A Coruña

17403

Research Site, York

20014

Research Site, Donostia / San Sebastian

21401

Research Site, Annapolis

23708

Research Site, Portsmouth

24014

Research Site, Roanoke

25123

Research Site, Brescia

25198

Research Site, Lleida

26006

Research Site, Logroño

26100

Research Site, Cremona

28040

Research Site, Madrid

28041

Research Site, Madrid

28046

Research Site, Madrid

28222

Research Site, Majadahonda

29010

Research Site, Málaga

29605

Research Site, Greenville

30008

Research Site, Murcia

30318

Research Site, Atlanta

31008

Research Site, Pamplona

32005

Research Site, Ourense

32503

Research Site, Pensacola

33011

Research Site, Oviedo

34362

Research Site, Haifa

35016

Research Site, Las Palmas de Gran Canaria

36604

Research Site, Mobile

37126

Research Site, Verona

37236

Research Site, Nashville

37916

Research Site, Knoxville

38010

Research Site, Santa Cruz de Tenerife

38120

Research Site, Memphis

39008

Research Site, Santander

40002

Research Site, Segovia

40202

Research Site, Louisville

40503

Research Site, Lexington

41009

Research Site, Seville

42781

Research Site, Vienna

43204

Research Site, Reus

45004

Research Site, Toledo

46014

Research Site, Valencia

48075

Research Site, Southfield

48903

Research Site, Barakaldo

50009

Research Site, Zaragoza

50012

Research Site, Zaragoza

56126

Research Site, Pisa

60026

Research Site, Glenview

60068

Research Site, Park Ridge

60805

Research Site, Evergreen Park

64111

Research Site, Kansas City

64239

Research Site, Tel Aviv

72100

Research Site, Brindisi

72205

Research Site, Little Rock

75071

Research Site, McKinney

75246

Research Site, Dallas

75702

Research Site, Tyler

76104

Research Site, Fort Worth

78503

Research Site, McAllen

79902

Research Site, El Paso

85224

Research Site, Chandler

90064

Research Site, Los Angeles

90127

Research Site, Palermo

91120

Research Site, Jerusalem

95126

Research Site, Catania

95403

Research Site, Santa Rosa

97401

Research Site, Eugene

98201

Research Site, Everett

8410101

Research Site, Beersheba

02111

Research Site, Boston

55102-2389

Research Site, Saint Paul

08103

Research Site, Camden

07932

Research Site, Florham Park

38138-1762

Research Site, Germantown

75230-6899

Research Site, Dallas

78229-3900

Research Site, San Antonio

53215-3692

Research Site, Milwaukee

A-4600

Research Site, Wels

29308-014

Research Site, Cachoeiro de Itapemirim

40170-110

Research Site, Salvador

72115-700

Research Site, Brasília

30130-100

Research Site, Belo Horizonte

80040-170

Research Site, Curitiba

90619-900

Research Site, Porto Alegre

88301-220

Research Site, Itajaí

90035-001

Research Site, Porto Alegre

01236030

Research Site, São Paulo

06455-010

Research Site, São Paulo

T2N 4N2

Research Site, Calgary

V3V 1Z2

Research Site, Surrey

VSZ 4E6

Research Site, Vancouver

K7L 2V7

Research Site, Kingston

N2G 1G3

Research Site, Kitchener

H3T 1E2

Research Site, Montreal

G1S 4L8

Research Site, Québec

00133

Research Site, Roma

00144

Research Site, Roma

03203

Research Site, Elche

07120

Research Site, Palma de Mallorca

08908

Research Site, L'Hospitalet de Llobregat

'8036

Research Site, Barcelona

08003

Research Site, Barcelona

08035

Research Site, Barcelona

08036

Research Site, Barcelona

09006

Research Site, Burgos

CH-5405

Research Site, Basel

CH-4410

Research Site, Liestal

BD20 6TD

Research Site, Keighley

HA6 2RN

Research Site, Rickmansworth

BT47 6SB

Research Site, Londonderry

IV2 3BW

Research Site, Inverness

TA1 5DA

Research Site, Taunton

CV2 2DX

Research Site, Coventry

HD3 3EA

Research Site, Huddersfield

LS9 7TF

Research Site, Leeds

M20 4BX

Research Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT05592483 - An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter